Logo-bi
Bioimpacts. 2018;8(1): 59-75. doi: 10.15171/bi.2018.08
PMID: 29713603        PMCID: PMC5915710

Review

Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective

Ailar Nakhlband, Morteza Eskandani, Yadollah Omidi ORCID, Nazli Saeedi, Samad Ghafari, Jaleh Barar * ORCID, Alireza Garjani *

Cited by CrossRef: 52

1- AbuZahra H. Kirenol protects against oxidized low-density lipoprotein induced damages in endothelial cells. Braz J Biol. 2024;84 [Crossref]
2- Brusini R, Dormont F, Cailleau C, Nicolas V, Peramo A, Varna M, Couvreur P. Squalene-based nanoparticles for the targeting of atherosclerotic lesions. International Journal of Pharmaceutics. 2020;581:119282 [Crossref]
3- Mehryab F, Taghizadeh F, Goshtasbi N, Merati F, Rabbani S, Haeri A. Exosomes as cutting-edge therapeutics in various biomedical applications: An update on engineering, delivery, and preclinical studies. Biochimie. 2023;213:139 [Crossref]
4- Fonseca A, Kohler T, Ahmed D. Ultrasound‐Controlled Swarmbots Under Physiological Flow Conditions. Adv Materials Inter. 2022;9(26) [Crossref]
5- Li J, Ding F, Qian X, Sun J, Ge Z, Yang L, Cheng Z. Anti-inflammatory cytokine IL10 loaded cRGD liposomes for the targeted treatment of atherosclerosis. Journal of Microencapsulation. 2021;38(6):357 [Crossref]
6- Noels H, Weber C, Koenen R. Chemokines as Therapeutic Targets in Cardiovascular Disease. ATVB. 2019;39(4):583 [Crossref]
7- Dhawan U, Singhal A, Subramanian M. Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution. Pharmacological Research. 2021;170:105699 [Crossref]
8- Vallejo-Zamora J, Vega-Cantu Y, Rodriguez C, Cordell G, Rodriguez-Garcia A. Drug-Eluting, Bioresorbable Cardiovascular Stents─Challenges and Perspectives. ACS Appl Bio Mater. 2022;5(10):4701 [Crossref]
9- Omidian H, Babanejad N, Cubeddu L. Nanosystems in Cardiovascular Medicine: Advancements, Applications, and Future Perspectives. Pharmaceutics. 2023;15(7):1935 [Crossref]
10- Wang J, Zhang H, Wan W, Yang H, Zhao J. Advances in nanotechnological approaches for the detection of early markers associated with severe cardiac ailments. Nanomedicine. 2024;19(16):1487 [Crossref]
11- Cheng M, Liu Q, Liu W, Yuan F, Feng J, Jin Y, Tu L. Engineering micelles for the treatment and diagnosis of atherosclerosis. Journal of Drug Delivery Science and Technology. 2021;63:102473 [Crossref]
12- Su X, Rakshit M, Das P, Gupta I, Das D, Pramanik M, Ng K, Kwan J. Ultrasonic Implantation and Imaging of Sound-Sensitive Theranostic Agents for the Treatment of Arterial Inflammation. ACS Appl Mater Interfaces. 2021;13(21):24422 [Crossref]
13- Chen L, Jiang Z, Akakuru O, Yang L, Li J, Ma S, Wu A. Recent progress in the detection and treatment of atherosclerosis by nanoparticles. Materials Today Chemistry. 2020;17:100280 [Crossref]
14- Yan Y, Thakur M, van der Vorst E, Weber C, Döring Y. Targeting the chemokine network in atherosclerosis. Atherosclerosis. 2021;330:95 [Crossref]
15- Pala R, Pattnaik S, Busi S, Nauli S. Nanomaterials as Novel Cardiovascular Theranostics. Pharmaceutics. 2021;13(3):348 [Crossref]
16- Zhang X, Centurion F, Misra A, Patel S, Gu Z. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment. Advanced Drug Delivery Reviews. 2023;194:114709 [Crossref]
17- Dai Z, Zhang Y, Meng Y, Li S, Suonan Z, Sun Y, Ji J, Shen Q, Zheng H, Xue Y. Targeted delivery of nutraceuticals derived from food for the treatment of obesity and its related complications. Food Chemistry. 2023;418:135980 [Crossref]
18- Zhu H, Liang H, Gao Z, Zhang X, He Q, He C, Cai C, Chen J. MiR-483-5p downregulation alleviates ox-LDL induced endothelial cell injury in atherosclerosis. BMC Cardiovasc Disord. 2023;23(1) [Crossref]
19- Kiaie N, Gorabi A, Penson P, Watts G, Johnston T, Banach M, Sahebkar A. A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome. Drug Discovery Today. 2020;25(1):58 [Crossref]
20- Zakirov F, Zhang D, Grechko A, Wu W, Poznyak A, Orekhov A. Lipid‐based gene delivery to macrophage mitochondria for atherosclerosis therapy. Pharmacology Res & Perspec. 2020;8(2) [Crossref]
21- Wu Y, Deng C, Xu J, Wang W, Chen Y, Qin X, Lv Q, Xie M. Enhanced Local Delivery of microRNA-145a-5P into Mouse Aorta via Ultrasound-Targeted Microbubble Destruction Inhibits Atherosclerotic Plaque Formation. Mol Pharmaceutics. 2023;20(2):1086 [Crossref]
22- Perera B, Wu Y, Nguyen N, Ta H. Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs. Materials Today Bio. 2023;22:100767 [Crossref]
23- Zamanlu M, Eskandani M, Barar J, Jaymand M, Pakchin P, Farhoudi M. Enhanced thrombolysis using tissue plasminogen activator (tPA)-loaded PEGylated PLGA nanoparticles for ischemic stroke. Journal of Drug Delivery Science and Technology. 2019;53:101165 [Crossref]
24- Taiariol L, Chaix C, Farre C, Moreau E. Click and Bioorthogonal Chemistry: The Future of Active Targeting of Nanoparticles for Nanomedicines?. Chem Rev. 2022;122(1):340 [Crossref]
25- Farokhi S, Razavi Z, Mavaei M, Shadab A, Afkhami H, Sardarabadi H. New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells. Discov Appl Sci. 2024;6(8) [Crossref]
26- Skuratovskaia D, Vulf M, Komar A, Kirienkova E, Litvinova L. Promising Directions in Atherosclerosis Treatment Based on Epigenetic Regulation Using MicroRNAs and Long Noncoding RNAs. Biomolecules. 2019;9(6):226 [Crossref]
27- Zhang Y, Gao J, Bai Y, Wang Q, Sun D, Sun X, Lv B. Numerical simulation of the fractional Maxwell fluid flow in locally narrow artery. Computer Methods in Biomechanics and Biomedical Engineering. 2023;26(11):1272 [Crossref]
28- Gonella V, Hanser F, Vorwerk J, Odenbach S, Baumgarten D. Influence of local particle concentration gradient forces on the flow-mediated mass transport in a numerical model of magnetic drug targeting. Journal of Magnetism and Magnetic Materials. 2021;525:167490 [Crossref]
29- Leal B, Velasco B, Cambón A, Pardo A, Fernandez-Vega J, Arellano L, Al-Modlej A, Mosquera V, Bouzas A, Prieto G, Barbosa S, Taboada P. Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors. Pharmaceutics. 2022;14(2):258 [Crossref]
30- Hossaini Nasr S, Rashidijahanabad Z, Ramadan S, Kauffman N, Parameswaran N, Zinn K, Qian C, Arora R, Agnew D, Huang X. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles. Nanoscale. 2020;12(17):9541 [Crossref]
31- Muruganantham S, Krishnaswami V, Alagarsamy S, Kandasamy R. Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis. CDT. 2021;22(4):399 [Crossref]
32- Vandghanooni S, Eskandani M, Sanaat Z, Omidi Y. Recent advances in the production, reprogramming, and application of CAR-T cells for treating hematological malignancies. Life Sciences. 2022;309:121016 [Crossref]
33- Safary A, Akbarzadeh Khiavi M, Mousavi R, Barar J, Rafi M. Enzyme replacement therapies: what is the best option?. Bioimpacts. 2018;8(3):153 [Crossref]
34- Vigne J, Cabella C, Dézsi L, Rustique E, Couffin A, Aid R, Anizan N, Chauvierre C, Letourneur D, Le Guludec D, Rouzet F, Hyafil F, Mészáros T, Fülöp T, Szebeni J, Cordaro A, Oliva P, Mourier V, Texier I. Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE−/− mice. Nanomedicine: Nanotechnology, Biology and Medicine. 2020;25:102157 [Crossref]
35- Setia A, Mehata A, Priya V, Pawde D, Jain D, Mahto S, Muthu M. Current Advances in Nanotheranostics for Molecular Imaging and Therapy of Cardiovascular Disorders. Mol Pharmaceutics. 2023;20(10):4922 [Crossref]
36- Ikram M, Rasheed S. Genetics of Dravet Syndrome and its Targeted Therapy by Nanomedicine: A Roadmap for Future Treatment of Drug Resistant Seizures. CMP. 2023;16(4):475 [Crossref]
37- Li C, Naveed M, Dar K, Liu Z, Baig M, Lv R, Saeed M, Dingding C, Feng Y, Xiaohui Z. Therapeutic advances in cardiac targeted drug delivery: from theory to practice. Journal of Drug Targeting. 2021;29(3):235 [Crossref]
38- Díaz-Pozo P, Canet F, Grirrane A, Lopez-Domenech S, Herance J, Apostolova N, Luna-Marco C, Rovira-Llopis S, Marti M, Morillas C, Rocha M, Garcia H, Victor V. Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes. Antioxidants. 2022;11(11):2297 [Crossref]
39- Wadekar P, Salunkhe V. Formulation and evaluation of nanobiotherapeutics of Terminalia arjuna through plant tissue culture for atherosclerosis. Futur J Pharm Sci. 2024;10(1) [Crossref]
40- Jafari S, Bakhshaei A, Eskandani M, Molavi O. Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells. ASSAY and Drug Development Technologies. 2022;20(8):339 [Crossref]
41- Sayadi K, Rahdar A, Hajinezhad M, Nikazar S, Susan M. Atorvastatin-loaded SBA-16 nanostructures: Synthesis, physical characterization, and biochemical alterations in hyperlipidemic rats. Journal of Molecular Structure. 2020;1202:127296 [Crossref]
42- Nurhidayah D, Maruf A, Zhang X, Liao X, Wu W, Wang G. Advanced drug-delivery Systems: Mechanoresponsive Nanoplatforms Applicable in Atherosclerosis Management. Nanomedicine (Lond). 2019;14(23):3105 [Crossref]
43- Chopra H, Bibi S, Mishra A, Tirth V, Yerramsetty S, Murali S, Ahmad S, Mohanta Y, Attia M, Algahtani A, Islam F, Hayee A, Islam S, Baig A, Emran T, Senthilkumar N. Nanomaterials: A Promising Therapeutic Approach for Cardiovascular Diseases. Journal of Nanomaterials. 2022;2022(1) [Crossref]
44- Dilip D, Rupal R, Jain S, Borase K, Borse C, Badhe S, Ganesh D. Nanosponges for Poorly Water-soluble Drugs: Recent Advancements, Patents, and Future Prospective. Scopus Indexed. 2024;17(4):7519 [Crossref]
45- Kumar R, Gulia K. The convergence of nanotechnology‐stem cell, nanotopography‐mechanobiology, and biotic‐abiotic interfaces: Nanoscale tools for tackling the top killer, arteriosclerosis, strokes, and heart attacks. Nano Select. 2021;2(4):655 [Crossref]
46- Massahi Khosrowshahi F, Ebrahimi-Hosseinzadeh B, Hatamian-Zarmi A. Sumac (Rhus coriaria) Extract Loaded-Mesoporous Silica Nanoparticle Efficiently as a Controlled Drug Delivery System for the Treatment of Atherosclerosis. J Inorg Organomet Polym. 2024;34(2):793 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge